Log in

NASDAQ:VICLVical News Headlines

Notice: This company has been marked as potentially delisted and may not be actively trading.
$0.95
-0.04 (-4.03 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.95
Now: $0.95
$0.99
50-Day Range
$0.68
MA: $1.24
$3.15
52-Week Range
$0.60
Now: $0.95
$1.47
Volume875,400 shs
Average Volume1.44 million shs
Market Capitalization$21.76 million
P/E RatioN/A
Dividend YieldN/A
Beta0.32

Headlines

Vical (NASDAQ VICL) News Headlines

Source:
DateHeadline
Recent Discovery in the Cure for Herpes is Overshadowed by the Covid -19 Quest for a Vaccine - Yahoo FinanceRecent Discovery in the Cure for Herpes is Overshadowed by the Covid -19 Quest for a Vaccine - Yahoo Finance
finance.yahoo.com - July 7 at 1:36 PM
Inovio Pharma (INO) Expands Senior Management Team - StreetInsider.comInovio Pharma (INO) Expands Senior Management Team - StreetInsider.com
www.streetinsider.com - June 26 at 12:58 AM
INOVIO adds talent to management team - Seeking AlphaINOVIO adds talent to management team - Seeking Alpha
seekingalpha.com - June 25 at 9:56 AM
ADMA Biologics (ADMA) Reports Election of Martha J. Demski to Board - StreetInsider.comADMA Biologics (ADMA) Reports Election of Martha J. Demski to Board - StreetInsider.com
www.streetinsider.com - June 24 at 1:41 PM
ADMA Biologics Announces Martha J. Demski Elected to Board of Directors - GlobeNewswireADMA Biologics Announces Martha J. Demski Elected to Board of Directors - GlobeNewswire
www.globenewswire.com - June 23 at 10:39 PM
ADMA Biologics Announces Martha J. Demski Elected to Board of Directors - StreetInsider.comADMA Biologics Announces Martha J. Demski Elected to Board of Directors - StreetInsider.com
www.streetinsider.com - June 23 at 7:37 AM
Is Johnson and Johnson Stock a Buy? - NasdaqIs Johnson and Johnson Stock a Buy? - Nasdaq
www.nasdaq.com - May 28 at 5:27 PM
Did Northwest Biotherapeutics Just Check Off 1 Box Needed for Its Stock to Double? - Motley FoolDid Northwest Biotherapeutics Just Check Off 1 Box Needed for Its Stock to Double? - Motley Fool
www.fool.com - May 28 at 7:26 AM
Did Northwest Biotherapeutics Just Check Off 1 Box Needed for Its Stock to Double?Did Northwest Biotherapeutics Just Check Off 1 Box Needed for Its Stock to Double?
finance.yahoo.com - May 28 at 7:26 AM
MatriSys Bioscience Inc. is pleased to announce that Magda Marquet PhD has been appointed Chairwoman of MatriSys Board of Directors - GlobeNewswireMatriSys Bioscience Inc. is pleased to announce that Magda Marquet PhD has been appointed Chairwoman of MatriSys' Board of Directors - GlobeNewswire
www.globenewswire.com - May 26 at 2:54 PM
Edited Transcript of VICL earnings conference call or presentation 13-May-20 8:30pm GMTEdited Transcript of VICL earnings conference call or presentation 13-May-20 8:30pm GMT
finance.yahoo.com - May 17 at 7:50 PM
Cytomegalovirus (HHV-5) Infections: Global Clinical Trials Review H1, 2020 - ResearchAndMarkets.com - Business WireCytomegalovirus (HHV-5) Infections: Global Clinical Trials Review H1, 2020 - ResearchAndMarkets.com - Business Wire
www.businesswire.com - May 6 at 3:43 PM
Cytomegalovirus (HHV-5) Infections: Global Clinical Trials Review H1, 2020 - ResearchAndMarkets.com - Yahoo FinanceCytomegalovirus (HHV-5) Infections: Global Clinical Trials Review H1, 2020 - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - May 5 at 6:18 PM
Visiongain Report: The Gene Therapy Market is Projected to Grow at a CAGR of 32% in the First Half of the Forecast Period - Yahoo FinanceVisiongain Report: The Gene Therapy Market is Projected to Grow at a CAGR of 32% in the First Half of the Forecast Period - Yahoo Finance
finance.yahoo.com - April 17 at 8:52 PM
Cytomegalovirus (HHV-5) Infections Clinical Trials Scenario, 2020: The Top Companies, Leading Drugs - Yahoo FinanceCytomegalovirus (HHV-5) Infections Clinical Trials Scenario, 2020: The Top Companies, Leading Drugs - Yahoo Finance
finance.yahoo.com - April 2 at 7:05 AM
Edited Transcript of VICL earnings conference call or presentation 18-Mar-20 8:30pm GMTEdited Transcript of VICL earnings conference call or presentation 18-Mar-20 8:30pm GMT
finance.yahoo.com - March 19 at 8:15 AM
Ajinomoto Bio-Pharma Services Announces Formation of External Advisory Board - Yahoo FinanceAjinomoto Bio-Pharma Services Announces Formation of External Advisory Board - Yahoo Finance
finance.yahoo.com - March 11 at 9:04 AM
Form 8-K Brickell Biotech, Inc. For: Feb 10 - StreetInsider.comForm 8-K Brickell Biotech, Inc. For: Feb 10 - StreetInsider.com
www.streetinsider.com - February 10 at 7:03 PM
Asia-Pacific DNA Vaccines Market 2019-2027 - Surge in New Vaccine Development Drives the Market - PRNewswireAsia-Pacific DNA Vaccines Market 2019-2027 - Surge in New Vaccine Development Drives the Market - PRNewswire
www.prnewswire.com - December 30 at 5:05 PM
Brickell Bio Announces Third Quarter 2019 Financial Results and Provides Corporate Update - Yahoo FinanceBrickell Bio Announces Third Quarter 2019 Financial Results and Provides Corporate Update - Yahoo Finance
finance.yahoo.com - November 14 at 7:20 AM
Brickell Biotech Completes Merger with Vical Nasdaq:BBI - GlobeNewswireBrickell Biotech Completes Merger with Vical Nasdaq:BBI - GlobeNewswire
www.globenewswire.com - September 3 at 6:32 PM
Brickell Biotech Completes Merger with Vical - NasdaqBrickell Biotech Completes Merger with Vical - Nasdaq
www.nasdaq.com - September 3 at 10:24 AM
Brickell Biotech Completes Merger with VicalBrickell Biotech Completes Merger with Vical
feeds.benzinga.com - September 3 at 7:25 AM
Vical (VICL) Shareholders Approve Brickell Merger, 1-for-7 Reverse Split - StreetInsider.comVical (VICL) Shareholders Approve Brickell Merger, 1-for-7 Reverse Split - StreetInsider.com
www.streetinsider.com - August 31 at 8:47 AM
Vical Stockholders Approve Reverse Stock Split and Merger with Brickell - Yahoo FinanceVical Stockholders Approve Reverse Stock Split and Merger with Brickell - Yahoo Finance
finance.yahoo.com - August 30 at 11:52 PM
Vical approves reverse stock split and merger with BrickellVical approves reverse stock split and merger with Brickell
seekingalpha.com - August 30 at 6:51 PM
Options Traders Expect Huge Moves in Vical (VICL) StockOptions Traders Expect Huge Moves in Vical (VICL) Stock
finance.yahoo.com - August 30 at 6:51 PM
Vical Stockholders Approve Reverse Stock Split and Merger with BrickellVical Stockholders Approve Reverse Stock Split and Merger with Brickell
finance.yahoo.com - August 30 at 6:51 PM
Form DEFA14A VICAL INC - StreetInsider.comForm DEFA14A VICAL INC - StreetInsider.com
www.streetinsider.com - August 20 at 6:40 PM
Moore Kuehn, PLLC Encourages Vical Incorporated (VICL), ASV Holdings, Inc. (ASV), PCM, Inc. (PCMI), WageWorks, Inc. (WAGE), and Acacia Communications, Inc. (ACIA) Investors to Contact Firm - PRNewswireMoore Kuehn, PLLC Encourages Vical Incorporated (VICL), ASV Holdings, Inc. (ASV), PCM, Inc. (PCMI), WageWorks, Inc. (WAGE), and Acacia Communications, Inc. (ACIA) Investors to Contact Firm - PRNewswire
www.prnewswire.com - August 8 at 6:48 PM
Moore Kuehn, PLLC Encourages Vical Incorporated (VICL), ASV Holdings, Inc. (ASV), PCM, Inc. (PCMI), WageWorks, Inc. (WAGE), and Acacia Communications, Inc. (ACIA) Investors to Contact FirmMoore Kuehn, PLLC Encourages Vical Incorporated (VICL), ASV Holdings, Inc. (ASV), PCM, Inc. (PCMI), WageWorks, Inc. (WAGE), and Acacia Communications, Inc. (ACIA) Investors to Contact Firm
www.prnewswire.com - August 8 at 3:50 PM
URGENT: Monteverde & Associates PC is Investigating the Following Transaction - Yahoo FinanceURGENT: Monteverde & Associates PC is Investigating the Following Transaction - Yahoo Finance
finance.yahoo.com - July 31 at 5:46 PM
URGENT: Monteverde & Associates PC is Investigating the Following TransactionURGENT: Monteverde & Associates PC is Investigating the Following Transaction
finance.yahoo.com - July 31 at 5:46 PM
SHAREHOLDER ALERT: WeissLaw LLP Investigates Vical Incorporated Acquisition - PRNewswireSHAREHOLDER ALERT: WeissLaw LLP Investigates Vical Incorporated Acquisition - PRNewswire
www.prnewswire.com - June 12 at 4:01 PM
SHAREHOLDER ALERT: WeissLaw LLP Investigates Vical Incorporated AcquisitionSHAREHOLDER ALERT: WeissLaw LLP Investigates Vical Incorporated Acquisition
finance.yahoo.com - June 12 at 4:01 PM
Rejecting The Vical-Brickell Reverse Merger Could Unlock 50% Upside - Seeking AlphaRejecting The Vical-Brickell Reverse Merger Could Unlock 50% Upside - Seeking Alpha
seekingalpha.com - June 12 at 12:33 PM
Boulder biotech firm enters reverse merger valued at up to $60 millionBoulder biotech firm enters reverse merger valued at up to $60 million
finance.yahoo.com - June 3 at 5:51 PM
5 Stocks To Watch For June 3, 2019 - Benzinga5 Stocks To Watch For June 3, 2019 - Benzinga
www.benzinga.com - June 3 at 9:27 AM
Vical and Brickell Announce Merger Agreement - Yahoo FinanceVical and Brickell Announce Merger Agreement - Yahoo Finance
finance.yahoo.com - June 3 at 9:27 AM
Vical and Brickell Announce Merger AgreementVical and Brickell Announce Merger Agreement
finance.yahoo.com - June 3 at 9:27 AM
The Margin Of Safety Does Not Look Sufficient For VicalThe Margin Of Safety Does Not Look Sufficient For Vical
seekingalpha.com - May 13 at 9:35 AM
Form 10-Q VICAL INC For: Mar 31 - StreetInsider.comForm 10-Q VICAL INC For: Mar 31 - StreetInsider.com
www.streetinsider.com - May 3 at 9:39 AM
Will Vical (VICL) Report Negative Q1 Earnings? What You Should KnowWill Vical (VICL) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - April 25 at 6:11 PM
Vical Is A Net Net In Liquidation Trading At Half Its CashVical Is A Net Net In Liquidation Trading At Half Its Cash
seekingalpha.com - March 7 at 5:49 PM
Vical to Discontinue Clinical Development of VL-2397 as it Considers Near Term Strategic Alternatives - GlobeNewswireVical to Discontinue Clinical Development of VL-2397 as it Considers Near Term Strategic Alternatives - GlobeNewswire
globenewswire.com - February 21 at 10:07 AM
Vical: 4Q Earnings SnapshotVical: 4Q Earnings Snapshot
finance.yahoo.com - February 20 at 9:49 AM
Vical to Discontinue Clinical Development of VL-2397 as it Considers Near Term Strategic AlternativesVical to Discontinue Clinical Development of VL-2397 as it Considers Near Term Strategic Alternatives
finance.yahoo.com - February 19 at 5:56 PM
This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.